To further explore the clinical correlation between CDC37L1 and PPIA and their association with clinicopathological parameters of HCC patients, we accessed the expression of CDC37L1 and PPIA in a tissue microarray containing 80 pairs of HCC and adjacent normal tissues derived from patients who received sorafenib treatment after surgery via immunohistochemistry (IHC) staining. Here, CDC37L1 is linked to hepatocellular carcinoma.